The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized trial of a multimodal intervention to enhance sexual function and quality of life (QOL) in hematopoietic stem cell transplant (HSCT) survivors.
 
Areej El-Jawahri
Stock and Other Ownership Interests - Tuesday Health
Consulting or Advisory Role - AIM Specialty Health; GlaxoSmithKline; Incyte; Novartis
Research Funding - Blue Note Therapeutics
 
Jennifer B. Reese
No Relationships to Disclose
 
Lara Traeger
No Relationships to Disclose
 
Don S. Dizon
Stock and Other Ownership Interests - Doximity; Midi
Honoraria - UpToDate
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Pfizer
Research Funding - Bristol-Myers Squibb (Inst)
Other Relationship - Global Cancer Institute
 
Sharon L. Bober
Honoraria - UpToDate
Research Funding - Apex Neuro
 
Julie Vanderklish
No Relationships to Disclose
 
Nora K. Horick
Employment - Northwest Biotherapeutics (I)
Stock and Other Ownership Interests - Northwest Biotherapeutics (I)
Patents, Royalties, Other Intellectual Property - An immediate family member holds patents, has patents pending, and receives royalties from a technology relating to health or medicine. (I)
 
Richard Newcomb
Employment - Vertex (I)
Stock and Other Ownership Interests - TimeDoc; Vertex (I)
 
Zachariah Michael DeFilipp
Consulting or Advisory Role - Incyte; Inhibrx; MorphoSys; Ono Pharmaceutical; PharmaBiome; Sanofi
Research Funding - Incyte; REGiMMUNE; Taiho Oncology
 
Yi-Bin Albert Chen
Leadership - ImmunoFree
Stock and Other Ownership Interests - ImmunoFree
Consulting or Advisory Role - Alexion Pharmaceuticals; Astellas Pharma; Editas Medicine; Incyte; Magenta Therapeutics; Novo Nordisk; Pharmacosmos; Takeda; Vor Biopharma
 
Jennifer S. Temel
No Relationships to Disclose